Clinical Trial Update: Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis [Phase 3]

View source ↗

Summary

Phase III study assessing safety and efficacy of a single intra-articular administration of JTA-004 for symptomatic knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Osteoarthritis of the Knee

Drugs mentioned

• JTA-004

Snippet

Sponsor: Bone Therapeutics S.A | Conditions: Symptomatic Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED